Aquestive Therapeutics Inc
AQST
Get informed when a big investor buys or sells
+ FollowMarket Cap$409.14M
Close$
$-1.86
146.1% downside
Current Fair Value
146.1% downsideOvervalued by 146.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $409.14 Million |
|---|---|
| Enterprise Value | $347.24 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.76 |
| Beta | 1.45 |
| Outstanding Shares | 122,609,995 |
Return
| Return on Equity | 202.36% |
|---|---|
| Return on Assets | -48.83% |
| Return on Invested Capital | -52.03% |
Valuation & Multiples
| P/E Ratio | -6.75 |
|---|---|
| PEG | 10.41 |
| Price to Sales | - |
| Price to Book Ratio | -4.04 |
| Enterprise Value to Revenue | 6.91 |
| Enterprise Value to EBIT | -6.1 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | -1.43 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$10.90 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$11.42 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 34.52% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.15%▼ 57.79% |
|---|---|
| Total Invested | $5.87M▼ 98.12% |
| Investors Holding | 6▼ 180.00% |
ESG Score
No data